Research News and Research

RSS

Chronic fatigue syndrome not linked to virus

The latest research from the University College London, the Wellcome Trust Sanger Institute, and University of Oxford, England suggests that chronic fatigue syndrome (CFS) is not caused by the virus XMRV (xenotropic murine leukemia virus-related virus). The team says that earlier research that linked the virus to CFS was faulty because of contamination of mouse cell DNA samples in the laboratory.

21 Dec 2010

Echinacea only offers modest benefit in common cold: study

In a large clinical trial involving more than 700 adults and children researchers showed that the popular herbal remedy Echinacea can cut only half a day from a week long common cold. Echinacea has been marketed for a long time for the common cold. Echinacea, also known as purple coneflower has been shown to have benefits in some earlier studies while some show no benefits.

21 Dec 2010

Breast feed for smarter kids

A news study published in the journal Pediatrics this Monday shows that babies who are breastfed for longer than six months may reap he benefits of having better brain function right into school. The benefit may be particularly so in boys.

21 Dec 2010

Working more closely with community will make research more meaningful, say Johns Hopkins faculty

A survey conducted by Johns Hopkins faculty found strong support among their peers for working more closely with the minority, inner-city community that surrounds the institution. Overall, 91 percent of faculty responders said closer ties make research more relevant to those it ultimately serves, and 87 percent said it improves the quality of research.

21 Dec 2010

Medicaid Health Plans of America selects MedAssurant for advanced analytics in healthcare delivery

MedAssurant Inc., a leading provider of data-driven healthcare solutions, today announced that Medicaid Health Plans of America (MHPA) has selected MedAssurant to provide advanced analytics to establish priorities and to inform best practices in healthcare delivery settings for Medicaid patients.

21 Dec 2010

Isis commences ISIS-APOCIIIRx Phase 1 trial in hypertriglyceridemia

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-APOCIIIRx, an antisense drug designed to lower triglycerides to treat a variety of diseases associated with elevated triglycerides. Hypertriglyceridemia, a condition characterized by elevated levels of triglycerides, is an independent risk factor for cardiovascular disease and is a component of numerous cardiovascular and metabolic diseases, including metabolic syndrome.

21 Dec 2010

Pro-Pharmaceuticals, Mount Sinai collaborate to evaluate anti-fibrotic effects of Galectin-targeting compounds

Pro-Pharmaceuticals, Inc., the leading developer of Galectin therapeutics to treat cancer and fibrosis, today announced it has entered into a new research collaboration with Mount Sinai School of Medicine to evaluate in pre-clinical models, the anti-fibrotic effects of several of the Company's novel, Galectin-targeting compounds.

21 Dec 2010

First Edition: December 21, 2010

Today's headlines reveal the health law challenges presented by the Senate's current deal to fund the federal government and from a antitrust suit in Michigan.

21 Dec 2010

AutoGenomics introduces first automated molecular assay for Familial Mediterranean Fever

AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.

21 Dec 2010

The Children's Agenda delivered to California's incoming policymakers

Citing the state's failure to prioritize kids, a comprehensive plan addressing the systemic education and health problems undermining children's development was delivered to California's incoming policymakers today. Authored by Children Now, the state's leading multi-issue research and advocacy group for children, The Children's Agenda details the top ten, high-priority, high-impact actions California policymakers should take to reverse the declining status of children.

21 Dec 2010

UCB's Cimzia and Centocor's Simponi penetrate first line biologic position in RA

In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc. finds that newer biologic agents such as UCB's Cimzia and Centocor OrthoBiotech's Simponi, although lagging in overall market share, have begun to penetrate the first line biologic position primarily at the expense of Pfizer/Amgen's Enbrel and Abbott's Humira.

21 Dec 2010

Study on why whole orange is better than components

In time for Christmas, BYU nutritionists are squeezing all the healthy compounds out of oranges to find just the right mixture responsible for their age-old health benefits.

21 Dec 2010

Study aims to deliver safer bone marrow transplant treatment strategy in patients with multiple myeloma cancer

A national clinical trial, which opens imminently, will aim to assess the impact of a novel anti-cancer drug in the setting of donor bone marrow transplantation for myeloma.

21 Dec 2010

Whites with mutations more likely to be susceptible to cocaine abuse

Nearly one in five whites could carry a genetic variant that substantially increases their odds of being susceptible to severe cocaine abuse, according to new research.

21 Dec 2010

Investigator to receive AGA-General Mills Bell Institute of Health and Nutrition Research Scholar Award

The American Gastroenterological Association Foundation for Digestive Health and Nutrition announced that Anisa Shaker, MD, is the recipient of the AGA-General Mills Bell Institute of Health and Nutrition Research Scholar Award in Gut Physiology and Health.

21 Dec 2010

Novel pen measures stress levels

In the future, more and more products will be able to interpret what users are feeling and use that information in a smart way. To illustrate the power of this theory, researcher Miguel Bruns Alonso has developed a pen which can measure the stress levels of the person using it, and can actually help to reduce that stress. In experiments, the heart rate of people who used the anti-stress pen fell by an average of five percent. On Wednesday, 23 December, Miguel Bruns Alonso will receive his PhD degree from TU Delft based on his research into this subject.

21 Dec 2010

Study provides evidence on prevalence of two separate mosquito species which carry malaria parasite

In notable back-to-back papers appearing in the prestigioous journal Science in October, teams of researchers, one led by Nora Besansky, a professor of biological sciences and a member of the Eck Institute for Global Health at the University of Notre Dame, provided evidence that Anopheles gambiae, which is one of the major mosquito carriers of the malaria parasite in Sub-Saharan Africa, is evolving into two separate species with different traits.

21 Dec 2010

B-Bridge International unveils first brainwave athletic trainer

B-Bridge International proudly unveils the first brainwave athletic trainer. Powered by NeuroSky, the leader in mass-market Brain-Computer Interface technology, the BrainAthlete system is the first sports training unit available for general consumers to track an athlete's level of concentration, helping them find their "zone." Engineered into a standard golf visor, three non-invasive contact points in the headband monitor the EEG electrical activity from the brain to determine the athlete's mental states.

21 Dec 2010

Majority of Massachusetts physician groups use statewide results to improve patient experiences

Most Massachusetts physician groups are using results from a statewide patient survey to help improve patient experiences, but a significant number are not making use of the information or are making relatively limited efforts, according to a new RAND Corporation study.

21 Dec 2010

Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins

Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.

21 Dec 2010

Research News and Research

Chronic fatigue syndrome not linked to virus

Echinacea only offers modest benefit in common cold: study

Breast feed for smarter kids

Working more closely with community will make research more meaningful, say Johns Hopkins faculty

Medicaid Health Plans of America selects MedAssurant for advanced analytics in healthcare delivery

Isis commences ISIS-APOCIIIRx Phase 1 trial in hypertriglyceridemia

Pro-Pharmaceuticals, Mount Sinai collaborate to evaluate anti-fibrotic effects of Galectin-targeting compounds

First Edition: December 21, 2010

AutoGenomics introduces first automated molecular assay for Familial Mediterranean Fever

The Children's Agenda delivered to California's incoming policymakers

UCB's Cimzia and Centocor's Simponi penetrate first line biologic position in RA

Study on why whole orange is better than components

Study aims to deliver safer bone marrow transplant treatment strategy in patients with multiple myeloma cancer

Whites with mutations more likely to be susceptible to cocaine abuse

Investigator to receive AGA-General Mills Bell Institute of Health and Nutrition Research Scholar Award

Novel pen measures stress levels

Study provides evidence on prevalence of two separate mosquito species which carry malaria parasite

B-Bridge International unveils first brainwave athletic trainer

Majority of Massachusetts physician groups use statewide results to improve patient experiences

Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins

A guide to advancing biotherapeutic research eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News